Mesoblast announced results from a Phase 3 trial of its allogeneic mesenchymal precursor cell (MPC) therapy rexlemestrocel-L in patients with […]
Reistone Biopharma announced positive results from the phase 2 AMBER2 trial evaluating SHR0302, in patients with moderate to severe ulcerative […]
Aclaris Therapeutics announced positive preliminary topline results from a phase 2 trial evaluating ATI-450, an investigational oral MK2 inhibitor, in […]
Dr. Vivek Datta, a neuropsychiatrist with University of California, San Francisco, recently shared on local media in The City that […]
In addition to the stages (incubation, symptomatic, early pulmonary & late pulmonary) associated with a SARS-CoV-2 infection, known as COVID-19, two […]
Revance Therapeutics reported results from its Phase 2 clinical trial of DaxibotulinumtoxinA for Injection for the management of plantar fasciitis, […]
Amgen and AstraZeneca announced positive results from NAVIGATOR, a phase 3 trial evaluating tezepelumab versus placebo, both added to standard […]
Gilead and Galapagos presented late-breaking data from the phase 2b/3 SELECTION trial at the 2020 United European Gastroenterology Week (UEGW) […]
Swedish Orphan Biovitrum and Selecta Biosciences reported topline data from the phase 2 COMPARE study, which evaluated the efficacy of […]
Abivax (Euronext Paris: FR0012333284 – ABVX), a clinical-stage biotechnology company harnessing the immune system to develop novel treatments for inflammatory […]
